Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 53 entries
Sorted by: Best Match Show Resources per page
Origins, production, and utilization of cassava in Burkina Faso, a contribution of a neglected crop to household food security.

Food science & nutrition

Guira F, Some K, Kabore D, Sawadogo-Lingani H, Traore Y, Savadogo A.
PMID: 28572925
Food Sci Nutr. 2016 Jul 20;5(3):415-423. doi: 10.1002/fsn3.408. eCollection 2017 May.

Cassava (

Cite
Guira F, Some K, Kabore D, et al. Origins, production, and utilization of cassava in Burkina Faso, a contribution of a neglected crop to household food security. Food Sci Nutr. 2016;5(3):415-423doi: 10.1002/fsn3.408.
Guira, F., Some, K., Kabore, D., Sawadogo-Lingani, H., Traore, Y., & Savadogo, A. (2017). Origins, production, and utilization of cassava in Burkina Faso, a contribution of a neglected crop to household food security. Food science & nutrition, 5(3), 415-423. https://doi.org/10.1002/fsn3.408
Guira, Flibert, et al. "Origins, production, and utilization of cassava in Burkina Faso, a contribution of a neglected crop to household food security." Food science & nutrition vol. 5,3 (2017): 415-423. doi: https://doi.org/10.1002/fsn3.408
Guira F, Some K, Kabore D, Sawadogo-Lingani H, Traore Y, Savadogo A. Origins, production, and utilization of cassava in Burkina Faso, a contribution of a neglected crop to household food security. Food Sci Nutr. 2016 Jul 20;5(3):415-423. doi: 10.1002/fsn3.408. eCollection 2017 May. PMID: 28572925; PMCID: PMC5448348.
Copy Download .nbib Format: NLM
[Not Available].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

Queruel V, Kabore R, Guillaume A, Moreau K, Leffondre K, Couzi L, Quinart A, Rogier J, Tauzin-Fin P, Merville P, Robert G, Pasticier G, Bensadoun H, Ferrière J, Bernhard J.
PMID: 26544295
Prog Urol. 2015 Nov;25(13):764-5. doi: 10.1016/j.purol.2015.08.101.

No abstract available.

Cite
Queruel V, Kabore R, Guillaume A, et al. Quelle valeur accorder à l'IMC dans l'évaluation de la morbidité périopératoire de la transplantation rénale ? [Not Available]. Prog Urol. 2015;25(13):764-5doi: 10.1016/j.purol.2015.08.101.
Queruel, V., Kabore, R., Guillaume, A., Moreau, K., Leffondre, K., Couzi, L., Quinart, A., Rogier, J., Tauzin-Fin, P., Merville, P., Robert, G., Pasticier, G., Bensadoun, H., Ferrière, J., & Bernhard, J. (2015). Quelle valeur accorder à l'IMC dans l'évaluation de la morbidité périopératoire de la transplantation rénale ? [Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 25(13), 764-5. https://doi.org/10.1016/j.purol.2015.08.101
Queruel, V, et al. "Quelle valeur accorder à l'IMC dans l'évaluation de la morbidité périopératoire de la transplantation rénale ?" [Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie vol. 25,13 (2015): 764-5. doi: https://doi.org/10.1016/j.purol.2015.08.101
Queruel V, Kabore R, Guillaume A, Moreau K, Leffondre K, Couzi L, Quinart A, Rogier J, Tauzin-Fin P, Merville P, Robert G, Pasticier G, Bensadoun H, Ferrière J, Bernhard J. Quelle valeur accorder à l'IMC dans l'évaluation de la morbidité périopératoire de la transplantation rénale ? [Not Available]. Prog Urol. 2015 Nov;25(13):764-5. doi: 10.1016/j.purol.2015.08.101. French. PMID: 26544295.
Copy Download .nbib Format: NLM
Prostate Cancer Presenting with Parietal Bone Metastasis.

Case reports in urology

Kirakoya B, Pare AK, Abubakar BM, Kabore M.
PMID: 28377829
Case Rep Urol. 2017;2017:1928570. doi: 10.1155/2017/1928570. Epub 2017 Mar 09.

Bone metastases from prostate cancer are very common. They are usually located on the axial skeleton. However, cranial bone metastases especially to the parietal bone are rare. We report a case of metastatic prostate cancer presenting with left parietal...

Cite
Kirakoya B, Pare AK, Abubakar BM, et al. Prostate Cancer Presenting with Parietal Bone Metastasis. Case Rep Urol. 2017;2017:1928570doi: 10.1155/2017/1928570.
Kirakoya, B., Pare, A. K., Abubakar, B. M., & Kabore, M. (2017). Prostate Cancer Presenting with Parietal Bone Metastasis. Case reports in urology, 20171928570. https://doi.org/10.1155/2017/1928570
Kirakoya, Brahima, et al. "Prostate Cancer Presenting with Parietal Bone Metastasis." Case reports in urology vol. 2017 (2017): 1928570. doi: https://doi.org/10.1155/2017/1928570
Kirakoya B, Pare AK, Abubakar BM, Kabore M. Prostate Cancer Presenting with Parietal Bone Metastasis. Case Rep Urol. 2017;2017:1928570. doi: 10.1155/2017/1928570. Epub 2017 Mar 09. PMID: 28377829; PMCID: PMC5362717.
Copy Download .nbib Format: NLM
Prostate cancer outcome in Burkina Faso.

Infectious agents and cancer

Kabore FA, Zango B, Sanou A, Yameogo C, Kirakoya B.
PMID: 21992406
Infect Agent Cancer. 2011 Sep 23;6:S6. doi: 10.1186/1750-9378-6-S2-S6. Epub 2011 Sep 23.

INTRODUCTION: African-American black men race is one of non-modifiable risk factors confirmed for prostate cancer. Many studies have been done in USA among African- American population to evaluate prostate cancer disparities. Compared to the USA very few data are...

Cite
Kabore FA, Zango B, Sanou A, et al. Prostate cancer outcome in Burkina Faso. Infect Agent Cancer. 2011;6:S6doi: 10.1186/1750-9378-6-S2-S6.
Kabore, F. A., Zango, B., Sanou, A., Yameogo, C., & Kirakoya, B. (2011). Prostate cancer outcome in Burkina Faso. Infectious agents and cancer, 6S6. https://doi.org/10.1186/1750-9378-6-S2-S6
Kabore, Fasnéwindé A, et al. "Prostate cancer outcome in Burkina Faso." Infectious agents and cancer vol. 6 (2011): S6. doi: https://doi.org/10.1186/1750-9378-6-S2-S6
Kabore FA, Zango B, Sanou A, Yameogo C, Kirakoya B. Prostate cancer outcome in Burkina Faso. Infect Agent Cancer. 2011 Sep 23;6:S6. doi: 10.1186/1750-9378-6-S2-S6. Epub 2011 Sep 23. PMID: 21992406; PMCID: PMC3194185.
Copy Download .nbib Format: NLM
Iatrogenic Ureteral Injuries Associated with Gynecological and Surgical Procedures: Our Experience About 18 Cases and Literature Review.

Research and reports in urology

Ouattara A, Pare AK, Kabore FA, Yameogo C, Ky D, Bayané D, Ye D, Kambou T.
PMID: 34079774
Res Rep Urol. 2021 May 25;13:289-293. doi: 10.2147/RRU.S299590. eCollection 2021.

AIM: To describe the epidemiological aspects, etiology and outcome of iatrogenic ureteral injury repair at the urology division of Souro Teaching Hospital of Bobo Dioulasso (Burkina-Faso).PATIENTS AND METHODS: This was a retrospective descriptive study of consecutive patients with iatrogenic...

Cite
Ouattara A, Pare AK, Kabore FA, et al. Iatrogenic Ureteral Injuries Associated with Gynecological and Surgical Procedures: Our Experience About 18 Cases and Literature Review. Res Rep Urol. 2021;13:289-293doi: 10.2147/RRU.S299590.
Ouattara, A., Pare, A. K., Kabore, F. A., Yameogo, C., Ky, D., Bayané, D., Ye, D., & Kambou, T. (2021). Iatrogenic Ureteral Injuries Associated with Gynecological and Surgical Procedures: Our Experience About 18 Cases and Literature Review. Research and reports in urology, 13289-293. https://doi.org/10.2147/RRU.S299590
Ouattara, Adama, et al. "Iatrogenic Ureteral Injuries Associated with Gynecological and Surgical Procedures: Our Experience About 18 Cases and Literature Review." Research and reports in urology vol. 13 (2021): 289-293. doi: https://doi.org/10.2147/RRU.S299590
Ouattara A, Pare AK, Kabore FA, Yameogo C, Ky D, Bayané D, Ye D, Kambou T. Iatrogenic Ureteral Injuries Associated with Gynecological and Surgical Procedures: Our Experience About 18 Cases and Literature Review. Res Rep Urol. 2021 May 25;13:289-293. doi: 10.2147/RRU.S299590. eCollection 2021. PMID: 34079774; PMCID: PMC8164722.
Copy Download .nbib Format: NLM
Investigation of skin microbiota reveals Mycobacterium ulcerans-Aspergillus sp. trans-kingdom communication.

Scientific reports

Hammoudi N, Cassagne C, Million M, Ranque S, Kabore O, Drancourt M, Zingue D, Bouam A.
PMID: 33580189
Sci Rep. 2021 Feb 12;11(1):3777. doi: 10.1038/s41598-021-83236-7.

Mycobacterium ulcerans secrete a series of non-ribosomal-encoded toxins known as mycolactones that are responsible for causing a disabling ulceration of the skin and subcutaneous tissues named Buruli ulcer. The disease is the sole non-contagion among the three most common...

Cite
Hammoudi N, Cassagne C, Million M, et al. Investigation of skin microbiota reveals Mycobacterium ulcerans-Aspergillus sp. trans-kingdom communication. Sci Rep. 2021;11(1):3777doi: 10.1038/s41598-021-83236-7.
Hammoudi, N., Cassagne, C., Million, M., Ranque, S., Kabore, O., Drancourt, M., Zingue, D., & Bouam, A. (2021). Investigation of skin microbiota reveals Mycobacterium ulcerans-Aspergillus sp. trans-kingdom communication. Scientific reports, 11(1), 3777. https://doi.org/10.1038/s41598-021-83236-7
Hammoudi, N, et al. "Investigation of skin microbiota reveals Mycobacterium ulcerans-Aspergillus sp. trans-kingdom communication." Scientific reports vol. 11,1 (2021): 3777. doi: https://doi.org/10.1038/s41598-021-83236-7
Hammoudi N, Cassagne C, Million M, Ranque S, Kabore O, Drancourt M, Zingue D, Bouam A. Investigation of skin microbiota reveals Mycobacterium ulcerans-Aspergillus sp. trans-kingdom communication. Sci Rep. 2021 Feb 12;11(1):3777. doi: 10.1038/s41598-021-83236-7. PMID: 33580189; PMCID: PMC7881091.
Copy Download .nbib Format: NLM
Impact of Introducing Hepatitis B Birth Dose Vaccines into the Infant Immunization Program in Burkina Faso: Study Protocol for a Stepped Wedge Cluster Randomized Trial (NéoVac Study).

Vaccines

Tall H, Adam P, Tiendrebeogo ASE, Vincent JP, Schaeffer L, von Platen C, Fernandes-Pellerin S, Sawadogo F, Bokoum A, Bouda G, Ouattara S, Ouédraogo I, Herrant M, Boucheron P, Sawadogo A, Betsem E, Essoh A, Kabore L, Ouattara A, Méda N, Hien H, Gosset A, Giles-Vernick T, Boyer S, Kania D, Vray M, Shimakawa Y.
PMID: 34206058
Vaccines (Basel). 2021 Jun 01;9(6). doi: 10.3390/vaccines9060583.

To achieve global hepatitis elimination by 2030, it is critical to prevent the mother-to-child transmission (MTCT) of hepatitis B virus (HBV). Since 2009, the WHO has recommended administering hepatitis B vaccine to all neonates within 24 h of birth...

Cite
Tall H, Adam P, Tiendrebeogo ASE, et al. Impact of Introducing Hepatitis B Birth Dose Vaccines into the Infant Immunization Program in Burkina Faso: Study Protocol for a Stepped Wedge Cluster Randomized Trial (NéoVac Study). Vaccines (Basel). 2021;9(6)doi: 10.3390/vaccines9060583.
Tall, H., Adam, P., Tiendrebeogo, A. S. E., Vincent, J. P., Schaeffer, L., von Platen, C., Fernandes-Pellerin, S., Sawadogo, F., Bokoum, A., Bouda, G., Ouattara, S., Ouédraogo, I., Herrant, M., Boucheron, P., Sawadogo, A., Betsem, E., Essoh, A., Kabore, L., Ouattara, A., Méda, N., Hien, H., Gosset, A., Giles-Vernick, T., Boyer, S., Kania, D., Vray, M., & Shimakawa, Y. (2021). Impact of Introducing Hepatitis B Birth Dose Vaccines into the Infant Immunization Program in Burkina Faso: Study Protocol for a Stepped Wedge Cluster Randomized Trial (NéoVac Study). Vaccines, 9(6), . https://doi.org/10.3390/vaccines9060583
Tall, Haoua, et al. "Impact of Introducing Hepatitis B Birth Dose Vaccines into the Infant Immunization Program in Burkina Faso: Study Protocol for a Stepped Wedge Cluster Randomized Trial (NéoVac Study)." Vaccines vol. 9,6 (2021). doi: https://doi.org/10.3390/vaccines9060583
Tall H, Adam P, Tiendrebeogo ASE, Vincent JP, Schaeffer L, von Platen C, Fernandes-Pellerin S, Sawadogo F, Bokoum A, Bouda G, Ouattara S, Ouédraogo I, Herrant M, Boucheron P, Sawadogo A, Betsem E, Essoh A, Kabore L, Ouattara A, Méda N, Hien H, Gosset A, Giles-Vernick T, Boyer S, Kania D, Vray M, Shimakawa Y. Impact of Introducing Hepatitis B Birth Dose Vaccines into the Infant Immunization Program in Burkina Faso: Study Protocol for a Stepped Wedge Cluster Randomized Trial (NéoVac Study). Vaccines (Basel). 2021 Jun 01;9(6). doi: 10.3390/vaccines9060583. PMID: 34206058; PMCID: PMC8227098.
Copy Download .nbib Format: NLM
Safely resuming neglected tropical disease control activities during COVID-19: Perspectives from Nigeria and Guinea.

PLoS neglected tropical diseases

McKay S, Shu'aibu J, Cissé A, Knight A, Abdullahi F, Ibrahim A, Madaki S, Genovezos C, McCoy K, Downs P, Kabore A, Adamu H, Gobir IB, Chaitkin M, Standley CJ.
PMID: 34928945
PLoS Negl Trop Dis. 2021 Dec 20;15(12):e0009904. doi: 10.1371/journal.pntd.0009904. eCollection 2021 Dec.

Since its early spread in early 2020, the disease caused by the novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Coronavirus Disease 2019 (COVID-19) has caused mass disruptions to health services. These have included interruptions to programs that aimed...

Cite
McKay S, Shu'aibu J, Cissé A, et al. Safely resuming neglected tropical disease control activities during COVID-19: Perspectives from Nigeria and Guinea. PLoS Negl Trop Dis. 2021;15(12):e0009904doi: 10.1371/journal.pntd.0009904.
McKay, S., Shu'aibu, J., Cissé, A., Knight, A., Abdullahi, F., Ibrahim, A., Madaki, S., Genovezos, C., McCoy, K., Downs, P., Kabore, A., Adamu, H., Gobir, I. B., Chaitkin, M., & Standley, C. J. (2021). Safely resuming neglected tropical disease control activities during COVID-19: Perspectives from Nigeria and Guinea. PLoS neglected tropical diseases, 15(12), e0009904. https://doi.org/10.1371/journal.pntd.0009904
McKay, Stephanie, et al. "Safely resuming neglected tropical disease control activities during COVID-19: Perspectives from Nigeria and Guinea." PLoS neglected tropical diseases vol. 15,12 (2021): e0009904. doi: https://doi.org/10.1371/journal.pntd.0009904
McKay S, Shu'aibu J, Cissé A, Knight A, Abdullahi F, Ibrahim A, Madaki S, Genovezos C, McCoy K, Downs P, Kabore A, Adamu H, Gobir IB, Chaitkin M, Standley CJ. Safely resuming neglected tropical disease control activities during COVID-19: Perspectives from Nigeria and Guinea. PLoS Negl Trop Dis. 2021 Dec 20;15(12):e0009904. doi: 10.1371/journal.pntd.0009904. eCollection 2021 Dec. PMID: 34928945; PMCID: PMC8687572.
Copy Download .nbib Format: NLM
Restarting Neglected Tropical Diseases Programs in West Africa during the COVID-19 Pandemic: Lessons Learned and Best Practices.

The American journal of tropical medicine and hygiene

Kabore A, Palmer SL, Mensah E, Ettiegne-Traore V, Monteil R, Sintondji F, Tine J, Tesfaye D, Ogoussan K, Stukel D, Fuller BB, Sanchez K, Pou B, Dembele B, Weaver A, Reid S, Milord MD, Kassankogno Y, Seim A, Shott J.
PMID: 34670193
Am J Trop Med Hyg. 2021 Oct 20;105(6):1476-1482. doi: 10.4269/ajtmh.21-0408.

Countries across West Africa began reporting COVID-19 cases in February 2020. By March, the pandemic began disrupting activities to control and eliminate neglected tropical diseases (NTDs) as health ministries ramped up COVID-19-related policies and prevention measures. This was followed...

Cite
Kabore A, Palmer SL, Mensah E, et al. Restarting Neglected Tropical Diseases Programs in West Africa during the COVID-19 Pandemic: Lessons Learned and Best Practices. Am J Trop Med Hyg. 2021;105(6):1476-1482doi: 10.4269/ajtmh.21-0408.
Kabore, A., Palmer, S. L., Mensah, E., Ettiegne-Traore, V., Monteil, R., Sintondji, F., Tine, J., Tesfaye, D., Ogoussan, K., Stukel, D., Fuller, B. B., Sanchez, K., Pou, B., Dembele, B., Weaver, A., Reid, S., Milord, M. D., Kassankogno, Y., Seim, A., & Shott, J. (2021). Restarting Neglected Tropical Diseases Programs in West Africa during the COVID-19 Pandemic: Lessons Learned and Best Practices. The American journal of tropical medicine and hygiene, 105(6), 1476-1482. https://doi.org/10.4269/ajtmh.21-0408
Kabore, Achille, et al. "Restarting Neglected Tropical Diseases Programs in West Africa during the COVID-19 Pandemic: Lessons Learned and Best Practices." The American journal of tropical medicine and hygiene vol. 105,6 (2021): 1476-1482. doi: https://doi.org/10.4269/ajtmh.21-0408
Kabore A, Palmer SL, Mensah E, Ettiegne-Traore V, Monteil R, Sintondji F, Tine J, Tesfaye D, Ogoussan K, Stukel D, Fuller BB, Sanchez K, Pou B, Dembele B, Weaver A, Reid S, Milord MD, Kassankogno Y, Seim A, Shott J. Restarting Neglected Tropical Diseases Programs in West Africa during the COVID-19 Pandemic: Lessons Learned and Best Practices. Am J Trop Med Hyg. 2021 Oct 20;105(6):1476-1482. doi: 10.4269/ajtmh.21-0408. PMID: 34670193; PMCID: PMC8641318.
Copy Download .nbib Format: NLM
Pneumococcal Carriage in Burkina Faso After 13-Valent Pneumococcal Conjugate Vaccine Introduction: Results From 2 Cross-sectional Population-Based Surveys.

The Journal of infectious diseases

Kaboré L, Adebanjo T, Njanpop-Lafourcade BM, Ouangraoua S, Tarbangdo FT, Meda B, Velusamy S, Bicaba B, Aké F, McGee L, Yaro S, Betsem E, Gervaix A, Gessner BD, Whitney CG, Moïsi JC, Van Beneden CA.
PMID: 34469552
J Infect Dis. 2021 Sep 01;224:S258-S266. doi: 10.1093/infdis/jiab037.

BACKGROUND: Burkina Faso, a country in Africa's meningitis belt, introduced 13-valent pneumococcal conjugate vaccine (PCV13) in October 2013, with 3 primary doses given at 8, 12 and 16 weeks of age. To assess whether the new PCV13 program controlled...

Cite
Kaboré L, Adebanjo T, Njanpop-Lafourcade BM, et al. Pneumococcal Carriage in Burkina Faso After 13-Valent Pneumococcal Conjugate Vaccine Introduction: Results From 2 Cross-sectional Population-Based Surveys. J Infect Dis. 2021;224:S258-S266doi: 10.1093/infdis/jiab037.
Kaboré, L., Adebanjo, T., Njanpop-Lafourcade, B. M., Ouangraoua, S., Tarbangdo, F. T., Meda, B., Velusamy, S., Bicaba, B., Aké, F., McGee, L., Yaro, S., Betsem, E., Gervaix, A., Gessner, B. D., Whitney, C. G., Moïsi, J. C., & Van Beneden, C. A. (2021). Pneumococcal Carriage in Burkina Faso After 13-Valent Pneumococcal Conjugate Vaccine Introduction: Results From 2 Cross-sectional Population-Based Surveys. The Journal of infectious diseases, 224S258-S266. https://doi.org/10.1093/infdis/jiab037
Kaboré, Lassané, et al. "Pneumococcal Carriage in Burkina Faso After 13-Valent Pneumococcal Conjugate Vaccine Introduction: Results From 2 Cross-sectional Population-Based Surveys." The Journal of infectious diseases vol. 224 (2021): S258-S266. doi: https://doi.org/10.1093/infdis/jiab037
Kaboré L, Adebanjo T, Njanpop-Lafourcade BM, Ouangraoua S, Tarbangdo FT, Meda B, Velusamy S, Bicaba B, Aké F, McGee L, Yaro S, Betsem E, Gervaix A, Gessner BD, Whitney CG, Moïsi JC, Van Beneden CA. Pneumococcal Carriage in Burkina Faso After 13-Valent Pneumococcal Conjugate Vaccine Introduction: Results From 2 Cross-sectional Population-Based Surveys. J Infect Dis. 2021 Sep 01;224:S258-S266. doi: 10.1093/infdis/jiab037. PMID: 34469552; PMCID: PMC8409529.
Copy Download .nbib Format: NLM
Validation of the D:A:D chronic kidney disease risk score in people living with HIV: the IeDEA West Africa Cohort Collaboration.

HIV medicine

Poda A, Kabore NF, Malateste K, De Rekeneire N, Semde A, Bikinga Y, Patassi A, Chenal H, Messou E, Dabis F, Ekouevi DK, Jaquet A, Cournil A.
PMID: 33145918
HIV Med. 2021 Feb;22(2):113-121. doi: 10.1111/hiv.12982. Epub 2020 Nov 03.

OBJECTIVES: A risk score for long-term prediction of chronic kidney disease (CKD) in people living with HIV (PLHIV) has been developed using data from the D:A:D cohort. We assessed the performance of the D:A:D risk score in a cohort...

Cite
Poda A, Kabore NF, Malateste K, et al. Validation of the D:A:D chronic kidney disease risk score in people living with HIV: the IeDEA West Africa Cohort Collaboration. HIV Med. 2020;22(2):113-121doi: 10.1111/hiv.12982.
Poda, A., Kabore, N. F., Malateste, K., De Rekeneire, N., Semde, A., Bikinga, Y., Patassi, A., Chenal, H., Messou, E., Dabis, F., Ekouevi, D. K., Jaquet, A., & Cournil, A. (2021). Validation of the D:A:D chronic kidney disease risk score in people living with HIV: the IeDEA West Africa Cohort Collaboration. HIV medicine, 22(2), 113-121. https://doi.org/10.1111/hiv.12982
Poda, A, et al. "Validation of the D:A:D chronic kidney disease risk score in people living with HIV: the IeDEA West Africa Cohort Collaboration." HIV medicine vol. 22,2 (2021): 113-121. doi: https://doi.org/10.1111/hiv.12982
Poda A, Kabore NF, Malateste K, De Rekeneire N, Semde A, Bikinga Y, Patassi A, Chenal H, Messou E, Dabis F, Ekouevi DK, Jaquet A, Cournil A. Validation of the D:A:D chronic kidney disease risk score in people living with HIV: the IeDEA West Africa Cohort Collaboration. HIV Med. 2021 Feb;22(2):113-121. doi: 10.1111/hiv.12982. Epub 2020 Nov 03. PMID: 33145918; PMCID: PMC8593822.
Copy Download .nbib Format: NLM
Performance-based financing to increase utilization of maternal health services: Evidence from Burkina Faso.

SSM - population health

Steenland M, Robyn PJ, Compaore P, Kabore M, Tapsoba B, Zongo A, Haidara OD, Fink G.
PMID: 29349214
SSM Popul Health. 2017 Jan 10;3:179-184. doi: 10.1016/j.ssmph.2017.01.001. eCollection 2017 Dec.

Performance-based financing (PBF) programs are increasingly implemented in low and middle-income countries to improve health service quality and utilization. In April 2011, a PBF pilot program was launched in Boulsa, Leo and Titao districts in Burkina Faso with the...

Cite
Steenland M, Robyn PJ, Compaore P, et al. Performance-based financing to increase utilization of maternal health services: Evidence from Burkina Faso. SSM Popul Health. 2017;3:179-184doi: 10.1016/j.ssmph.2017.01.001.
Steenland, M., Robyn, P. J., Compaore, P., Kabore, M., Tapsoba, B., Zongo, A., Haidara, O. D., & Fink, G. (2017). Performance-based financing to increase utilization of maternal health services: Evidence from Burkina Faso. SSM - population health, 3179-184. https://doi.org/10.1016/j.ssmph.2017.01.001
Steenland, Maria, et al. "Performance-based financing to increase utilization of maternal health services: Evidence from Burkina Faso." SSM - population health vol. 3 (2017): 179-184. doi: https://doi.org/10.1016/j.ssmph.2017.01.001
Steenland M, Robyn PJ, Compaore P, Kabore M, Tapsoba B, Zongo A, Haidara OD, Fink G. Performance-based financing to increase utilization of maternal health services: Evidence from Burkina Faso. SSM Popul Health. 2017 Jan 10;3:179-184. doi: 10.1016/j.ssmph.2017.01.001. eCollection 2017 Dec. PMID: 29349214; PMCID: PMC5769027.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 53 entries